Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
An Acad Bras Cienc ; 94(suppl 3): e20201380, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36417598

RESUMO

This study aimed to verify the action of bioactive compounds from Brazilian plants on the leader genes involved in the SARS-CoV-2 pathway. The main human genes involved were identified in GeneCards and UNIPROT platforms, and an interaction network between leader genes was established in the STRING database. To design chemo-biology interactome networks and elucidate the interplay between genes related to the disease and bioactive plant compounds, the metasearch engine STITCH 3.1 was used. The analysis revealed that SMAD3 and CASP3 genes are leader genes, suggesting that the mechanism of action of the virus on host cells is associated with the molecular effects of these genes. Furthermore, the bioactive plant compounds, such as ascorbate, benzoquinone, ellagic acid, and resveratrol was identified as a promising adjuvant for the treatment inhibiting CASP3-mediated apoptosis. Bioactive plant compounds were verified as the main pathways enriched with KEGG and related to viral infection, assessments/immune/infections, and cell proliferation, which are potentially used for respiratory viral infections. The best-ranked molecule docked in the CASP3 binding site was rutin, while the SMAD3 binding site was resveratrol. In conclusion, this work identified several bioactive compounds from Brazilian plants showing potential antiviral functions that can directly or indirectly inhibit the new coronavirus.


Assuntos
Tratamento Farmacológico da COVID-19 , SARS-CoV-2 , Humanos , SARS-CoV-2/genética , Biologia Computacional , Caspase 3 , Resveratrol/farmacologia
2.
Sci Rep ; 9(1): 14082, 2019 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-31575942

RESUMO

Nano-emulsions are promising carriers for antigen delivery. Here, we evaluated the efficacy of a water-oil nano-emulsion containing concentrated, inactivated Clostridium novyi (C. novyi) type B supernatant culture (nano-iCnB) in protecting Swiss mice against a lethal dose of alpha toxin concentrated extract. Proteins were confirmed in the nano-iCnB and their stabilities were determined according physical parameters such as Zeta Potential (ZP). Biochemical, hematological parameters and morphological appearance of liver, spleen and thigh muscle alterations were examined to determine the safety of the compound. Partial protection against lethal doses was achieved in immunized mice despite low IgG titers. These data suggest that our nano-emulsion is a simple and efficient method of promoting antigen delivery for toxin-related diseases.


Assuntos
Vacinas Bacterianas/administração & dosagem , Toxinas Botulínicas Tipo A/toxicidade , Clostridium , Animais , Vacinas Bacterianas/imunologia , Clostridium/imunologia , Feminino , Fígado/patologia , Camundongos , Nanopartículas , Baço/patologia , Vacinas de Produtos Inativados/administração & dosagem , Vacinas de Produtos Inativados/imunologia
3.
Vet Immunol Immunopathol ; 138(1-2): 129-33, 2010 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-20709411

RESUMO

The aim of the present study was to evaluate and standardize the ToBI test in vitro as a substitute for the serum neutralization test in mice for quality control of clostridial vaccines. The ToBI test in vitro was used to evaluate 40 serum samples of known antibody content, obtained from rabbits immunized against clostridiosis with experimental vaccine. The correlation between epsilon antitoxin titers in rabbit sera, determined by the ToBI test and serum neutralization in mice, ranged from 0.222% to 0.452% in polyvalent vaccines and from 0.154% to 0.387% in monovalent vaccines. Interplate coefficients of variation were not significant, reaching 0.350% in polyvalent vaccines and 0.400% in monovalent vaccines, indicating high homogeneity. In conclusion, the ToBI test in vitro is suitable for assessing the potency of clostridial vaccines and may be used as an alternative method able to replace current in vivo tests.


Assuntos
Antitoxinas/sangue , Toxinas Bacterianas/antagonistas & inibidores , Clostridium perfringens/imunologia , Testes Sorológicos/métodos , Animais , Toxinas Bacterianas/imunologia , Vacinas Bacterianas/imunologia , Vacinas Bacterianas/normas , Infecções por Clostridium/diagnóstico , Infecções por Clostridium/imunologia , Infecções por Clostridium/prevenção & controle , Enterotoxemia/diagnóstico , Enterotoxemia/imunologia , Enterotoxemia/prevenção & controle , Imunização , Técnicas In Vitro , Camundongos , Testes de Neutralização/métodos , Controle de Qualidade , Coelhos , Testes Sorológicos/normas
4.
Artigo em Inglês | Sec. Est. Saúde SP, SESSP-IBPROD, Sec. Est. Saúde SP, SESSP-IBACERVO | ID: biblio-1068396

RESUMO

The aim of the present study was to evaluate and standardize the ToBI test in vitro as a substitute for the serum neutralization test in mice for quality control of clostridial vaccines. The ToBI test in vitro was used to evaluate 40 serum samples of known antibody content, obtained from rabbits immunized against clostridiosis with experimental vaccine. The correlation between epsilon antitoxin titers in rabbit sera, determined by the ToBI test and serum neutralization in mice, ranged from 0.222% to 0.452% in polyvalent vaccines and from 0.154% to 0.387% in monovalent vaccines. Interplate coefficients of variation were not significant, reaching 0.350% in polyvalent vaccines and 0.400% in monovalent vaccines, indicating high homogeneity. In conclusion, the ToBI test in vitro is suitable for assessing the potency of clostridial vaccines and may be used as an alternative method able to replace current in vivo tests.


Assuntos
Animais , Camundongos , Coelhos , Antitoxinas , Clostridium perfringens , Animais de Laboratório , Ética em Pesquisa
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA